Wilmington Investor Network

Wilmington Investor Network is a venture capital firm specializing in investments in early stage companies. The firm prefers to invest in technology, biotechnology, and medical devices companies. It invests in companies based in eastern North and South Carolina. The firm prefers to invest between $0.2 million to $0.5 million in an individual investment round. Wilmington Investor Network is based in Wilmington, North Carolina.

Carlos Parajon

Angel

17 past transactions

Consolidated Asset Recovery Systems, Inc. develops software for repossession management and marketing. The company offers Internet Based Electronic Asset Management (IBEAM), a technology for the tracking and recovery of assets for banks and dealers. It also provides repossession management, remarketing management electronic invoice payment, skip trace, audits and reports, legal demand, letter creation and making, automated notices, and field assist and door knock services. It supports the recovery of assets with a network of recovery agents in the United States. The company also serves lenders, dealers, and repossession/recovery agents. Consolidated Asset Recovery Systems, Inc. was founded in 2005 and is based in Raleigh, North Carolina. As of April 1, 2019, Consolidated Asset Recovery Systems, Inc. operates as a subsidiary of Primeritus Financial Services, Inc.

Amulet Pharmaceuticals

Series A in 2007
Amulet Pharmaceuticals discovers and develops novel therapeutics using their NORTECHâ„¢ technology to address known liabilities of current therapies serving large unmet markets. Their lead program (AMU-301) treats diabetic gastroparesis an unmet complication of diabetes affecting over 3 million women in the United States.

Sensory Analytics

Convertible Note in 2008
SpecMetrix systems deliver unmatched measurement data of coating and film layer thickness. Sensory Analytics suppliers award-winning SpecMetrix systems that deliver a transformative technology for real-time coating thickness and film layer measurement. The company's measurement systems measures in-process or offline, providing continuous data with nanometric precision down to sub-micron levels. These systems accurately measure the absolute thickness of any coating on any substrate and reduce costs by optimizing coating process control and product quality,.

ChaoLogix, Inc.

Series C in 2013
ChaoLogix, Inc. develops computing architecture and chip sets. It offers Chaologix system, a processor and architecture, based on chaotic circuit elements. This system is used in desktop and laptop personal computers, reconfigurable computer video cards for multimedia and gaming, computer network routers, chaotic search engine hardware, power cell phones, and light and adaptable avionics and satellite hardware. Its Chaologix system is also used in specialty computer chips, smart and low power medical devices, robotics, NASA and Department of Defense applications, speedier graphics cards, and self-healing and self-repairing computers. ChaoLogix was founded in 2005 and is based in Gainesville, Florida.

Metamaterial Technologies

Seed Round in 2015
MTI, a smart materials and photonics company which is changing the way we use, interact and benefit from light. From healthcare to defense, energy to aerospace– the possibilities are endless

ABK Biomedical

Angel Round in 2014
ABK Biomedical combines the clinical market with biomaterials. It specializes in improving treatment options for patients with hypervascular tumors. The company is dedicated to transforming an interventional radiology procedure called embolization.

roobrik

Venture Round in 2018
Roobrik, Inc. provides online decision tools that help caregivers, senior care providers, and clinicians to make health and care choices. The company was incorporated in 2013 and is based in Greensboro, North Carolina.

Gemmus Pharma

Series B in 2014
Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus' lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza. Gemmus has received support from the National Institute of Allergy and Infectious Disease (NIAID) and has completed a Series A round. Gemmus plans to file an investigational new drug (IND) application with the FDA for treatment of influenza infections in 2014.

Affinergy, LLC

Series B in 2006
Affinergy, LLC develops products that purify, concentrate, and remove cells and proteins from tissues and fluids for diagnostic and research applications. It develops a phage display platform that identifies peptides that bind to a variety of targets, such as drugs, proteins, and cells. The company’s products also include implantable devices that deliver and retain biologics at the site of implant in orthopedic procedures and soft tissue repair. The company was founded in 2003 and is based in Durham, North Carolina.

Basho Technologies

Series B in 2009
Basho is a distributed systems company dedicated to making software that is highly available, fault-tolerant and easy-to-operate at scale. Basho’s distributed database, Riak, and Basho’s cloud storage software, Riak CS, are used by fast growing Web businesses and by one third of the Fortune 50 to power their critical Web, mobile and social applications and their public and private cloud platforms. Riak and Riak CS are open source platforms. Riak Enterprise and Riak CS Enterprise offer enhanced multi-datacenter replication and 24×7 Basho support.

Trusted Metrics Inc

Seed Round in 2014
Trusted Metrics Inc., an information security company, offers a cloud-based security incident and event management platform called managed visibility platform with a focus on enabling enterprise visibility and rapid response by consolidating networking, systems, application, and security event information. Its managed visibility platform allows users to track their fixed and dynamic assets, including servers, workstations, and mobile devices; and user identities across multiple devices. The company’s platform also enables users to measure the level of security and protection within their enterprises by providing network monitoring, network, host and wireless intrusion detection, file integrity monitoring, event collaboration, long-term forensic log storage/retrieval, and more; and offers on-demand and scheduled customized alerting and reports. It serves local government, higher education, industrial control systems, insurance and legal, manufacturing, healthcare, and entertainment industries. The company was founded in 2010 and is based in Raleigh, North Carolina. As of July 10, 2018, Trusted Metrics Inc operates as a subsidiary of SolarWinds Worldwide, LLC.

Basho Technologies

Series B in 2009
Basho is a distributed systems company dedicated to making software that is highly available, fault-tolerant and easy-to-operate at scale. Basho’s distributed database, Riak, and Basho’s cloud storage software, Riak CS, are used by fast growing Web businesses and by one third of the Fortune 50 to power their critical Web, mobile and social applications and their public and private cloud platforms. Riak and Riak CS are open source platforms. Riak Enterprise and Riak CS Enterprise offer enhanced multi-datacenter replication and 24×7 Basho support.

Tunnel International

Seed Round in 2018
Tunnel allows real-time global cross-currency payments for free using our Distributed Ledger Technology. We provide our own payment rails, APIs and mobile apps.

Avhana Health Inc.

Seed Round in 2014
Avhana Health Inc. provides an application to simplify the healthcare provider workflow by offering the latest guidelines, actionable recommendations, and performance metrics—directly in their EHR. Its application features a dashboard for pre-visit planning, patient-specific recommendations for care, corresponding order suggestions that submit to the EHR, and a dashboard for tracking provider activity and performance. The company was founded in 2014 and is based in Baltimore, Maryland.

Gemmus Pharma

Series A in 2012
Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus' lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza. Gemmus has received support from the National Institute of Allergy and Infectious Disease (NIAID) and has completed a Series A round. Gemmus plans to file an investigational new drug (IND) application with the FDA for treatment of influenza infections in 2014.
At Wilmington Pharmaceuticals, they develop and out-license patient-friendly, fast-dissolving formulations for established medicines. They achieve FDA approval and rapid commercialization for their licensing partners, minimizing regulatory risk while maximizing economic opportunity. Their points of differentiation provide you with an ideal development partner.

Validic

Series A in 2014
Validic is the healthcare industry's premier technology platform for convenient, easy data access to a world of mobile health and in-home devices, fitness equipment, clinical sensors, activity wearables, smart bands, and wellness applications. Founded in 2010, Validic is headquartered in Durham, North Carolina.